Výsledky vyhledávání

Akademický článek

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer.

Autor: Cardillo TM; Immunomedics, Inc., Morris Plains, NJ 07950, USA., Rossi DL; Immunomedics, Inc., Morris Plains, NJ 07950, USA., Zalath MB; Immunomedics, Inc., Morris Plains, NJ 07950, USA., Liu D; Immunomedics, Inc., Morris Plains, NJ 07950, USA.; Currently employed with FrontAim Biomedicines Inc., Princeton, NJ 08540, USA., Arrojo R; Immunomedics, Inc., Morris Plains, NJ 07950, USA., Sharkey RM; Immunomedics, Inc., Morris Plains, NJ 07950, USA.; At the time the work was conducted, these authors were employees of Immunomedics, Inc., Morris Plains, NJ 07950, USA., Chang CH; Immunomedics, Inc., Morris Plains, NJ 07950, USA.; At the time the work was conducted, these authors were employees of Immunomedics, Inc., Morris Plains, NJ 07950, USA., Goldenberg DM; Immunomedics, Inc., Morris Plains, NJ 07950, USA.; Current address: Center for Molecular Medicine and Immunology, Mendham, NJ 07945, USA.; At the time the work was conducted, this author was Chairman and Chief Scientific Officer of Immunomedics, Inc., Morris Plains, NJ 07950, USA.

Publikováno v: Oncotarget [Oncotarget] 2020 Oct 27; Vol. 11 (43), pp. 3849-3862. Date of Electronic Publication: 2020 Oct 27 (Print Publication: 2020).

Zobrazit plný text záznamu

Akademický článek

IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma.

Autor: Cardillo TM; Immunomedics, Inc., Morris Plains, New Jersey. dmg.gscancer@att.net tcardillo@immunomedics.com., Govindan SV; Immunomedics, Inc., Morris Plains, New Jersey., Zalath MB; Immunomedics, Inc., Morris Plains, New Jersey., Rossi DL; Immunomedics, Inc., Morris Plains, New Jersey., Wang Y; Immunomedics, Inc., Morris Plains, New Jersey., Chang CH; Immunomedics, Inc., Morris Plains, New Jersey., Goldenberg DM; Immunomedics, Inc., Morris Plains, New Jersey. dmg.gscancer@att.net tcardillo@immunomedics.com.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2018 Jan; Vol. 17 (1), pp. 150-160. Date of Electronic Publication: 2017 Nov 13.

Zobrazit plný text záznamu

Akademický článek

Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells.

Autor: Chang CH; Immunomedics, Inc., Morris Plains, New Jersey. kchang@immunomedics.com.; IBC Pharmaceuticals, Inc., Morris Plains, New Jersey., Wang Y; Immunomedics, Inc., Morris Plains, New Jersey., Li R; Immunomedics, Inc., Morris Plains, New Jersey., Rossi DL; Immunomedics, Inc., Morris Plains, New Jersey., Liu D; Immunomedics, Inc., Morris Plains, New Jersey.; IBC Pharmaceuticals, Inc., Morris Plains, New Jersey., Rossi EA; Immunomedics, Inc., Morris Plains, New Jersey., Cardillo TM; Immunomedics, Inc., Morris Plains, New Jersey., Goldenberg DM; Immunomedics, Inc., Morris Plains, New Jersey.; IBC Pharmaceuticals, Inc., Morris Plains, New Jersey.

Publikováno v: Cancer research [Cancer Res] 2017 Oct 01; Vol. 77 (19), pp. 5384-5394. Date of Electronic Publication: 2017 Aug 17.

Zobrazit plný text záznamu

Akademický článek

Synthetic Lethality Exploitation by an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2 -wild-type Triple-Negative Breast Cancer.

Autor: Cardillo TM; Immunomedics, Inc., Morris Plains, New Jersey. dmg.gscancer@att.net tcardillo@immunomedics.com., Sharkey RM; Immunomedics, Inc., Morris Plains, New Jersey., Rossi DL; Immunomedics, Inc., Morris Plains, New Jersey., Arrojo R; Immunomedics, Inc., Morris Plains, New Jersey., Mostafa AA; Immunomedics, Inc., Morris Plains, New Jersey., Goldenberg DM; Immunomedics, Inc., Morris Plains, New Jersey. dmg.gscancer@att.net tcardillo@immunomedics.com.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Jul 01; Vol. 23 (13), pp. 3405-3415. Date of Electronic Publication: 2017 Jan 09.

Zobrazit plný text záznamu

Akademický článek

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling.

Autor: Li, Tianye^1,2 (AUTHOR), Niu, Mengke³ (AUTHOR), Zhou, Jianwei^1,2 (AUTHOR), Wu, Kongming³ (AUTHOR) kmwu@tjh.tjmu.edu.cn, Yi, Ming⁴ (AUTHOR) mingyi_onco@outlook.com

Publikováno v: Cell Communication & Signaling. 3/12/2024, Vol. 22 Issue 1, p1-18. 18p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.

Autor: Zhou, Ling¹ (AUTHOR), Lu, Yunlong² (AUTHOR), Liu, Wei³ (AUTHOR), Wang, Shanglong² (AUTHOR), Wang, Lingling¹ (AUTHOR), Zheng, Pengdou¹ (AUTHOR), Zi, Guisha¹ (AUTHOR), Liu, Huiguo¹ (AUTHOR), Liu, Wukun^2,4 (AUTHOR) liuwukun0000@njucm.edu.cn, Wei, Shuang^1,4 (AUTHOR) shuangwei@tjh.tjmu.edu.cn

Publikováno v: Experimental Hematology & Oncology. 3/1/2024, Vol. 13 Issue 1, p1-55. 55p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors.

Autor: Wei, Qing^1,2,3 (AUTHOR), Li, Peijing^2,4 (AUTHOR), Yang, Teng^2,5 (AUTHOR), Zhu, Jiayu⁶ (AUTHOR), Sun, Lu^2,7 (AUTHOR), Zhang, Ziwen^1,2 (AUTHOR), Wang, Lu⁸ (AUTHOR), Tian, Xuefei^2,9,10 (AUTHOR), Chen, Jiahui^2,3,11 (AUTHOR), Hu, Can^2,3,11 (AUTHOR), Xue, Junli¹² (AUTHOR), Ma, Letao^2,5 (AUTHOR), Shimura, Takaya¹³ (AUTHOR), Fang, Jianmin¹⁴ (AUTHOR), Ying, Jieer^1,2,3 (AUTHOR) jieerying@aliyun.com, Guo, Peng^2,3 (AUTHOR) guopeng@ucas.ac.cn, Cheng, Xiangdong^2,3,11 (AUTHOR) chengxd@zjcc.org.cn

Publikováno v: Journal of Hematology & Oncology. 1/4/2024, Vol. 17 Issue 1, p1-32. 32p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání